BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 1425975)

  • 1. AF102B, a muscarinic M1 receptor agonist, mimics some effects of acetylcholine on neurons of rat hippocampus slices.
    Segal M; Fisher A
    Eur J Pharmacol; 1992 Sep; 220(1):103-6. PubMed ID: 1425975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneity of muscarinic autoreceptors and heteroreceptors in the rat brain: effects of a novel M1 agonist, AF102B.
    Ono S; Saito Y; Ohgane N; Kawanishi G; Mizobe F
    Eur J Pharmacol; 1988 Oct; 155(1-2):77-84. PubMed ID: 3243333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. (+-)-cis-2-methyl-spiro(1,3-oxathiolane-5,3')quinuclidine, an M1 selective cholinergic agonist, attenuates cognitive dysfunctions in an animal model of Alzheimer's disease.
    Fisher A; Brandeis R; Karton I; Pittel Z; Gurwitz D; Haring R; Sapir M; Levy A; Heldman E
    J Pharmacol Exp Ther; 1991 Apr; 257(1):392-403. PubMed ID: 2019998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of a muscarinic (M1) receptor agonist on sympathetic nerve activity in rats].
    Saito Y
    Hokkaido Igaku Zasshi; 1993 Mar; 68(2):190-204. PubMed ID: 8509063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sympathoexcitatory action of a novel muscarinic receptor agonist, AF102B, and its blockade by pirenzepine.
    Yoshioka M; Togashi H; Matsumoto M; Morii K; Saito H
    Pharmacol Toxicol; 1990 Jul; 67(1):84-7. PubMed ID: 2395822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progress in medicinal chemistry of novel selective muscarinic agonists.
    Fisher A; Karton Y; Heldman E; Gurwitz D; Haring R; Meshulam H; Brandeis R; Pittel Z; Segall Y; Marciano D
    Drug Des Discov; 1993; 9(3-4):221-35. PubMed ID: 8400004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockade of hippocampal M1 muscarinic receptors impairs working memory performance of rats.
    Ohno M; Yamamoto T; Watanabe S
    Brain Res; 1994 Jul; 650(2):260-6. PubMed ID: 7953691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opposite modulation by muscarinic M1 and M3 receptors of acetylcholine release from guinea pig ileum as measured directly.
    Soejima O; Katsuragi T; Furukawa T
    Eur J Pharmacol; 1993 Nov; 249(1):1-6. PubMed ID: 7904245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NGF-dependent neurotrophic-like effects of AF102B, an M1 muscarinic agonist, in PC12M1 cells.
    Gurwitz D; Haring R; Pinkas-Kramarski R; Stein R; Heldman E; Karton Y; Fisher A
    Neuroreport; 1995 Feb; 6(3):485-8. PubMed ID: 7766849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of a M1 muscarinic receptor agonist on the central cholinergic system, evaluated by brain microdialysis.
    Ogane N; Takada Y; Iga Y; Kawanishi G; Mizobe F
    Neurosci Lett; 1990 Jun; 114(1):95-100. PubMed ID: 2381577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of M1- and M2-muscarinic drugs on striatal dopamine release and metabolism in freely moving rats.
    Xu M; Mizobe F; Yamamoto T; Kato T
    Brain Res; 1989 Aug; 495(2):232-42. PubMed ID: 2765928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Functional role of muscarinic M1 receptor for the ganglionic transmission in the rat superior cervical ganglion].
    Ikeda T
    Hokkaido Igaku Zasshi; 1997 May; 72(3):261-72. PubMed ID: 9226466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological studies on novel muscarinic agonists, 1-oxa-8-azaspiro[4.5]decane derivatives, YM796 and YM954.
    Wanibuchi F; Konishi T; Harada M; Terai M; Hidaka K; Tamura T; Tsukamoto S; Usuda S
    Eur J Pharmacol; 1990 Oct; 187(3):479-86. PubMed ID: 1963596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of muscarinic acetylcholine receptor-mediated synaptic responses by adenosine receptors in the rat hippocampus.
    Morton RA; Davies CH
    J Physiol; 1997 Jul; 502 ( Pt 1)(Pt 1):75-90. PubMed ID: 9234198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. L-689,660, a novel cholinomimetic with functional selectivity for M1 and M3 muscarinic receptors.
    Hargreaves RJ; McKnight AT; Scholey K; Newberry NR; Street LJ; Hutson PH; Semark JE; Harley EA; Patel S; Freedman SB
    Br J Pharmacol; 1992 Oct; 107(2):494-501. PubMed ID: 1422595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Muscarinic excitation and inhibition of neurons in the submucous plexus of the guinea-pig caecum.
    Mihara S; Nishi S
    Neuroscience; 1989; 31(1):247-57. PubMed ID: 2570377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. (+-)-cis-2-methyl-spiro(1,3-oxathiolane-5,3') quinuclidine (AF102B): a new M1 agonist attenuates cognitive dysfunctions in AF64A-treated rats.
    Fisher A; Brandeis R; Pittel Z; Karton I; Sapir M; Dachir S; Levy A; Heldman E
    Neurosci Lett; 1989 Jul; 102(2-3):325-31. PubMed ID: 2812509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of a novel cholinergic M1 agonist, AF102B, on ambulation and water drinking behavior in rats.
    Togashi H; Matsumoto M; Yoshioka M; Saito Y; Saito H
    Hokkaido Igaku Zasshi; 1991 Jan; 66(1):59-66. PubMed ID: 2004736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding sites for [3H]AF-DX 116 and effect of AF-DX 116 on endogenous acetylcholine release from rat brain slices.
    Lapchak PA; Araujo DM; Quirion R; Collier B
    Brain Res; 1989 Sep; 496(1-2):285-94. PubMed ID: 2804636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of the effects of the novel muscarinic receptor agonists L-689,660 and AF102B in tests of reference and working memory.
    Dawson GR; Bayley P; Channell S; Iversen SD
    Psychopharmacology (Berl); 1994 Jan; 113(3-4):361-8. PubMed ID: 7862846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.